These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 24357689)

  • 1. Death and dysfunction of transplanted β-cells: lessons learned from type 2 diabetes?
    Potter KJ; Westwell-Roper CY; Klimek-Abercrombie AM; Warnock GL; Verchere CB
    Diabetes; 2014 Jan; 63(1):12-9. PubMed ID: 24357689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing the loss of beta-cell mass in islet transplantation.
    Emamaullee JA; Shapiro AM
    Cell Transplant; 2007; 16(1):1-8. PubMed ID: 17436849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
    Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
    Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell applications in diabetes.
    Noguchi H
    J Stem Cells; 2012; 7(4):229-44. PubMed ID: 24196798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctions between islet neogenesis and β-cell replication: implications for reversal of Type 1 and 2 diabetes.
    Levetan C
    J Diabetes; 2010 Jun; 2(2):76-84. PubMed ID: 20923488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice.
    Casares S; Lin M; Zhang N; Teijaro JR; Stoica C; McEvoy R; Farber DL; Bona C; Brumeanu TD
    Transplantation; 2008 Jun; 85(12):1717-25. PubMed ID: 18580462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet transplantation: a realistic alternative for the treatment of insulin deficient diabetes mellitus.
    Kim KW
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S11-7. PubMed ID: 15563959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
    Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
    Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Islet neogenesis: a potential therapeutic tool in type 1 diabetes.
    Lipsett M; Aikin R; Castellarin M; Hanley S; Jamal AM; Laganiere S; Rosenberg L
    Int J Biochem Cell Biol; 2006; 38(4):498-503. PubMed ID: 16216541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet cell transplantation.
    Vaithilingam V; Sundaram G; Tuch BE
    Curr Opin Organ Transplant; 2008 Dec; 13(6):633-8. PubMed ID: 19060555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of islet amyloid in type 2 diabetes mellitus.
    Höppener JW; Lips CJ
    Int J Biochem Cell Biol; 2006; 38(5-6):726-36. PubMed ID: 16459127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences.
    Lupi R; Del Prato S
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S56-64. PubMed ID: 18640587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoring a functional beta-cell mass in diabetes.
    Pipeleers D; Chintinne M; Denys B; Martens G; Keymeulen B; Gorus F
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():54-62. PubMed ID: 18834433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
    Westermark P; Andersson A; Westermark GT
    Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic stress, IAPP and islet amyloid.
    Montane J; Klimek-Abercrombie A; Potter KJ; Westwell-Roper C; Bruce Verchere C
    Diabetes Obes Metab; 2012 Oct; 14 Suppl 3():68-77. PubMed ID: 22928566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet transplantation as a treatment for diabetes.
    Weir GC; Bonner-Weir S
    J Am Optom Assoc; 1998 Nov; 69(11):727-32. PubMed ID: 9844324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic beta cell allotransplant in double transgenic mouse model of type 1 diabetes mellitus.
    Grosu M; Stăvaru C; Guţu D; Radu DL
    Roum Arch Microbiol Immunol; 2007; 66(3-4):57-61. PubMed ID: 18928064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes.
    Huang CJ; Lin CY; Haataja L; Gurlo T; Butler AE; Rizza RA; Butler PC
    Diabetes; 2007 Aug; 56(8):2016-27. PubMed ID: 17475933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of type 1 diabetics by transplantation of isolated pancreatic islets].
    Ono J
    Rinsho Byori; 2006 Apr; 54(4):379-85. PubMed ID: 16722457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.